openPR Logo
Press release

Key Factor Supporting Pet Cancer Therapeutics Market Development in 2025: Rising Pet Healthcare Expenditure Sparks Growth In Pet Cancer Therapeutics Market

07-02-2025 02:31 PM CET | Health & Medicine

Press release from: The Business Research Company

Pet Cancer Therapeutics

Pet Cancer Therapeutics

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the Pet Cancer Therapeutics Market Size By 2025?
In recent times, there has been a swift expansion in the pet cancer therapeutics market size. The forecast indicates an increase from $0.39 billion in 2024 to $0.43 billion in 2025, embodying a compound annual growth rate (CAGR) of 10.8%. Factors that have contributed to the historical period growth include a surge in pet adoption, progress in veterinary medical science, raised awareness regarding pet health, the humanization of pets, and the broadening scope of veterinary services.

How Big Is the Pet Cancer Therapeutics Market Size Expected to Grow by 2029?
The pet cancer therapeutics market is predicted to experience considerable expansion in the upcoming years, increasing to $0.65 billion in 2029 with a CAGR of 10.7%. This progression in the projection period is due to factors like an aging pet population, improvements in cancer treatments, an upswing in veterinary oncology services, pet insurance and healthcare plans, and a worldwide spread of pet care services. Noteworthy trends during this forecast period are anticipated to include the growth of nutraceuticals and integrative therapies, the broader availability of targeted diagnostic tests, collaboration between veterinary and human oncology fields, the launch of new chemotherapeutic agents, and increased understanding and education for pet owners.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pet-cancer-therapeutics-global-market-report

Which Key Market Drivers Powering Pet Cancer Therapeutics Market Expansion and Growth?
The rise in spending on pet healthcare is anticipated to boost the pet cancer therapeutics market's expansion. The total money allocated to veterinary services, medications, and other pet health-related costs is what we refer to as pet healthcare expenditure. The burgeoning expenses on pet health care mirror the escalating inclination of pet owners to put money into their pet's health, leading to the amplified demand for pet cancer treatments. For example, the 2023 State of the Industry Report by the North American Pet Health Insurance Association (NAPHIA), an association of pet health insurance organizations in the United States, reported that the total count of insured pets in the United States stood at 4.8 million at the end of 2022, marking a 22% rise from 2021. Thus, the hike in pet healthcare expenditure is a driving force for the pet cancer therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9984&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Pet Cancer Therapeutics Market?
Leading firms in the pet cancer therapeutics market are advancing technologies, like epigenetic technology, to improve treatment efficiency and precision in cancer cell targeting. This ultimately betters the prognosis for pets battling cancer. Epigenetic technology involves techniques that alter gene expression without modifying the foundational DNA sequence. This can often affect cellular behavior and potential healing results. For instance, the US-based multinational epigenetics corporation, VolitionRx Limited unveiled the Nu.Q Vet Cancer Test in April 2024. This test is conducted on the Element i+ Analyzer and provides swift results, generally within approximately 6 minutes. It uses an enzyme-linked immunosorbent assay to identify circulating nucleosomes in the blood as a potential indicator of cancer.

What Are the Emerging Segments in the Pet Cancer Therapeutics Market?
The pet cancer therapeutics market covered in this report is segmented -

1) By Cancer Type: Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer
2) By Species: Dogs, Cats, Other Species
3) By Therapy: Chemotherapy, Radiation Therapy, Immunotherapy, TomoTherapy, Other Therapies
4) By End User: Veterinary Hospitals, Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, Other End Users

Subsegments:
1) By Melanoma: Surgical Interventions, Chemotherapy, Immunotherapy, Targeted Therapy
2) By Mast Cell Cancer: Surgery, Chemotherapy, Tyrosine Kinase Inhibitors, Radiation Therapy
3) By Lymphoma: Chemotherapy Protocols, Steroid Therapy, Radiation Therapy, Immunotherapy
4) By Mammary And Squamous Cell Cancer: Surgical Treatment, Chemotherapy, Radiation Therapy, Palliative Care Options

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9984&type=smp

Who Are the Global Leaders in the Pet Cancer Therapeutics Market?
Major companies operating in the pet cancer therapeutics market include AB Science, Boehringer Ingelheim GmbH, Elanco Animal Health, ELIAS Animal Health, Zoetis Inc., Anivive Lifesciences Inc., QBiotics Group Ltd., Regeneus Ltd., VetDC Inc., PetCure Oncology at Veterinary Radiosurgery and Imaging Center, Torigen Pharmaceuticals Inc., virology and bacteriology, Nippon Zenyaku Kogyo Co. Ltd., Vivesto AB, Dechra Pharmaceuticals plc, Norbrook Laboratories Ltd., AdvaVet Inc., Oasmia Pharmaceuticals AB, Zenoaq Co. Ltd., Morphogenesis Inc., Sumitomo Pharma Animal Health Co., Vetivax, CarthroniX Inc.

Which are the Top Profitable Regional Markets for the Pet Cancer Therapeutics Industry?
North America was the largest region in the pet cancer therapeutics market in 2024. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9984

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Factor Supporting Pet Cancer Therapeutics Market Development in 2025: Rising Pet Healthcare Expenditure Sparks Growth In Pet Cancer Therapeutics Market here

News-ID: 4089843 • Views:

More Releases from The Business Research Company

Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Preservation Technology Paves The Way For Xenotransplantation Advancements as a Key Influencer
Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Xenotransplantation Market Size By 2025? The market size of xenotransplantation has seen robust expansion in the past few years. The market value is projected to increase from $14.68 billion in 2024 to $15.82 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.8%.
Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Wood Based Panel Market Through 2025? In recent times, the market size of wood-based panels has seen considerable growth. The market which was valued at $176.85 billion in 2024 is projected to rise to $190.52 billion in 2025, showing a compound annual
Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Wireless Speakers Market Size Growth Forecast: What to Expect by 2025? In recent times, the wireless speakers market has experienced substantial expansion. The market size is expected to increase from $37.14 billion in 2024 to $45.71 billion in 2025, growing at a compound annual growth rate (CAGR) of 23.1%.
Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy Insights
Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Wind Turbine Casting Industry Market Size Be by 2025? The market size for wind turbine castings has seen solid growth in the past few years. Its value is projected to increase from $2.31 billion in 2024 to $2.46 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For